Stem Cell Transplant
Cord Blood Transplant for Blood Cancers and Diseases
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is for people who need cord blood transplants and best match cord blood units that are not FDA-licensed. Doctors will observe participants for up to a year after the transplant.
Virus Therapy
New Vaccine COH04S1 vs. mRNA COVID-19 Vaccine for Blood Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is studying a new vaccine, COH04S1, to see if it is better than the EUA SARS-CoV-2 vaccine in reducing the chances of contracting COVID-19 or developing a severe form of COVID-19 disease in patients with blood cancer who have received stem cell transplant or cellular therapy.
Behavioural Intervention
Multidisciplinary Health Intervention for Blood Cancer
Recruiting1 award
Duarte, California
This trial is studying a multidisciplinary intervention to help older adults with blood cancers who are planning a stem cell transplant. The intervention includes multiple healthcare professionals and is aimed at improving fitness and the ability to bounce back after transplant.
BMS-986158 + Ruxolitinib/Fedratinib for Myelofibrosis
Recruiting1 awardPhase 1 & 2
La Jolla, California
This trial is testing a new drug called BMS-986158 for patients with high-risk blood cancer. It aims to see if the drug works better alone or when combined with existing treatments, Ruxolitinib and Fedratinib. Ruxolitinib is the first FDA-approved JAK inhibitor for myeloproliferative neoplasms, effective in controlling symptoms and improving splenomegaly, but many patients develop disease progression with long-term use.
Popular Filters
Trials for Acute Myelogenous Leukemia Patients
Antimetabolites
Donor Lymphocyte Infusion for Blood Cancers
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if giving white blood cells from a donor to patients with high-risk blood cancers can reduce the risk of the cancer coming back. The goal is to see if this approach helps fight off remaining cancer cells and prevents relapse.
Alkylating agents
Reduced-Dose Cyclophosphamide for Blood Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if a lower dose of cyclophosphamide after a bone marrow transplant can help adults with difficult-to-treat blood cancers. The aim is to prevent complications from donor cells attacking the body while reducing side effects. The study focuses on patients who are older, less fit, or have not had success with other treatments.
Cognitive Training for Post-Transplant Cognitive Impairment
Recruiting1 award4 criteria
Birmingham, Alabama
This trial will test whether it is possible to enroll patients in a study to improve their thinking skills after they have had a hematopoietic cell transplant, as well as whether patients are interested in learning about their genetic risk for cognitive impairment after the transplant.
Trials for Acute Lymphoblastic Leukemia Patients
Antimetabolites
Donor Lymphocyte Infusion for Blood Cancers
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if giving white blood cells from a donor to patients with high-risk blood cancers can reduce the risk of the cancer coming back. The goal is to see if this approach helps fight off remaining cancer cells and prevents relapse.
Alkylating agents
Reduced-Dose Cyclophosphamide for Blood Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if a lower dose of cyclophosphamide after a bone marrow transplant can help adults with difficult-to-treat blood cancers. The aim is to prevent complications from donor cells attacking the body while reducing side effects. The study focuses on patients who are older, less fit, or have not had success with other treatments.
Cognitive Training for Post-Transplant Cognitive Impairment
Recruiting1 award4 criteria
Birmingham, Alabama
This trial will test whether it is possible to enroll patients in a study to improve their thinking skills after they have had a hematopoietic cell transplant, as well as whether patients are interested in learning about their genetic risk for cognitive impairment after the transplant.
Trials With No Placebo
Antimetabolites
Donor Lymphocyte Infusion for Blood Cancers
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if giving white blood cells from a donor to patients with high-risk blood cancers can reduce the risk of the cancer coming back. The goal is to see if this approach helps fight off remaining cancer cells and prevents relapse.
Alkylating agents
Reduced-Dose Cyclophosphamide for Blood Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if a lower dose of cyclophosphamide after a bone marrow transplant can help adults with difficult-to-treat blood cancers. The aim is to prevent complications from donor cells attacking the body while reducing side effects. The study focuses on patients who are older, less fit, or have not had success with other treatments.
Cognitive Training for Post-Transplant Cognitive Impairment
Recruiting1 award4 criteria
Birmingham, Alabama
This trial will test whether it is possible to enroll patients in a study to improve their thinking skills after they have had a hematopoietic cell transplant, as well as whether patients are interested in learning about their genetic risk for cognitive impairment after the transplant.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.